Literature DB >> 18655120

Dose-dependent changes in the synaptic strength on dopamine neurons and locomotor activity after cocaine exposure.

M J Wanat1, A Bonci.   

Abstract

Changes in synaptic strength on ventral tegmental area (VTA) dopamine neurons are thought to play a critical role in the development of addiction-related behaviors. However, it is unknown how a single injection of cocaine at different doses affects locomotor activity, behavioral sensitization, and glutamatergic synaptic strength on VTA dopamine neurons in mice. We observed that behavioral sensitization to a challenge cocaine injection scaled with the dose of cocaine received 1 day prior. Interestingly, the locomotor activity after the initial exposure to different doses of cocaine corresponded to the changes in glutamatergic strength on VTA dopamine neurons. These results in mice suggest that a single exposure to cocaine dose-dependently affects excitatory synapses on VTA dopamine neurons, and that this acute synaptic alteration is directly associated with the locomotor responses to cocaine and not to behavioral sensitization. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655120      PMCID: PMC5018993          DOI: 10.1002/syn.20546

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  31 in total

1.  Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats.

Authors:  S Schenk; B Partridge
Journal:  Pharmacol Biochem Behav       Date:  2000-08       Impact factor: 3.533

Review 2.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

3.  Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.

Authors:  Stephanie L Borgland; Robert C Malenka; Antonello Bonci
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

4.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

Authors:  A A Grace; B S Bunney
Journal:  Neuroscience       Date:  1983-10       Impact factor: 3.590

5.  Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

Authors:  P E Paulson; D M Camp; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine.

Authors:  P Vezina; J Stewart
Journal:  Brain Res       Date:  1989-10-09       Impact factor: 3.252

7.  Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure.

Authors:  Miriam Melis; Rosana Camarini; Mark A Ungless; Antonello Bonci
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

8.  Opioids block long-term potentiation of inhibitory synapses.

Authors:  Fereshteh S Nugent; Esther C Penick; Julie A Kauer
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

9.  Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine.

Authors:  P W Kalivas; B Weber
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

10.  Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences.

Authors:  T E Robinson; J B Becker; S K Presty
Journal:  Brain Res       Date:  1982-12-16       Impact factor: 3.252

View more
  9 in total

Review 1.  Phasic dopamine release in appetitive behaviors and drug addiction.

Authors:  Matthew J Wanat; Ingo Willuhn; Jeremy J Clark; Paul E M Phillips
Journal:  Curr Drug Abuse Rev       Date:  2009-05

Review 2.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

3.  Accelerated development of cocaine-associated dopamine transients and cocaine use vulnerability following traumatic stress.

Authors:  Zachary D Brodnik; Emily M Black; Rodrigo A España
Journal:  Neuropsychopharmacology       Date:  2019-09-20       Impact factor: 7.853

4.  First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians.

Authors:  Scott M Rawls; Tavni Patil; Ekaternia Yuvasheva; Robert B Raffa
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

5.  Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol.

Authors:  Emmanuel Valjent; Jesus Bertran-Gonzalez; Benjamin Aubier; Paul Greengard; Denis Hervé; Jean-Antoine Girault
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

6.  Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure.

Authors:  Matthew J Wanat; Dennis R Sparta; F Woodward Hopf; M Scott Bowers; Miriam Melis; Antonello Bonci
Journal:  Biol Psychiatry       Date:  2008-12-31       Impact factor: 13.382

Review 7.  Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine Pathway.

Authors:  Samantha E Yohn; Jordan Galbraith; Erin S Calipari; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2019-04-15       Impact factor: 4.418

8.  Episodic memories and their relevance for psychoactive drug use and addiction.

Authors:  Christian P Müller
Journal:  Front Behav Neurosci       Date:  2013-05-23       Impact factor: 3.558

Review 9.  Ventral Tegmental Area Afferents and Drug-Dependent Behaviors.

Authors:  Idaira Oliva; Matthew J Wanat
Journal:  Front Psychiatry       Date:  2016-03-07       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.